Jacques Ghysdael - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jacques Ghysdael

Showing results (31-40 of 36) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 36 results.

Molecular Cancer|January 17, 2023

Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALLCharlotte Smith, Aurore Touzart, Mathieu Simonin, et al.

EMBO Molecular Medicine|April 30, 2014

Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progressionBenjamin Uzan, Sandrine Poglio, Bastien Gerby, et al.

Cancer Discovery|June 30, 2016

Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell LeukemiaAmélie Trinquand, Nuno R Dos Santos, Christine Tran Quang, et al.

Cell Reports|November 26, 2013

Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitorsMichaela Waibel, Vanessa S Solomon, Deborah A Knight, et al.

Leukemia|June 8, 2026

A novel CD7-directed antibody-drug conjugate targeting BCL-XL with potent anti-leukemic activity in T-cell acute lymphoblastic leukemiaMariana L Oliveira, Kanokporn Nuantang, Grégoire Huré, et al.

Cancer Discovery|June 9, 2021

AXL Inhibition in Macrophages Stimulates Host-versus-Leukemia Immunity and Eradicates Naïve and Treatment-Resistant LeukemiaIrene Tirado-Gonzalez, Arnaud Descot, Devona Soetopo, et al.

Pageof 4

Search research articles

Showing results (31-40 of 36) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 36 results.

Molecular Cancer|January 17, 2023

Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALLCharlotte Smith, Aurore Touzart, Mathieu Simonin, et al.

EMBO Molecular Medicine|April 30, 2014

Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progressionBenjamin Uzan, Sandrine Poglio, Bastien Gerby, et al.

Cancer Discovery|June 30, 2016

Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell LeukemiaAmélie Trinquand, Nuno R Dos Santos, Christine Tran Quang, et al.

Cell Reports|November 26, 2013

Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitorsMichaela Waibel, Vanessa S Solomon, Deborah A Knight, et al.

Leukemia|June 8, 2026

A novel CD7-directed antibody-drug conjugate targeting BCL-XL with potent anti-leukemic activity in T-cell acute lymphoblastic leukemiaMariana L Oliveira, Kanokporn Nuantang, Grégoire Huré, et al.

Cancer Discovery|June 9, 2021

AXL Inhibition in Macrophages Stimulates Host-versus-Leukemia Immunity and Eradicates Naïve and Treatment-Resistant LeukemiaIrene Tirado-Gonzalez, Arnaud Descot, Devona Soetopo, et al.

Pageof 4